You just read:

Health Canada Approves ACTEMRA® (tocilizumab) Subcutaneous For Use In Adult Patients Living With Moderately To Severely Active Rheumatoid Arthritis

News provided by

Roche Canada

May 08, 2014, 08:00 ET